Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
Status:
Completed
Trial end date:
2020-04-13
Target enrollment:
Participant gender:
Summary
In this multi-center, randomized, control study, the investigators will evaluate the efficacy
and safety of glucocorticoid in combination with standard care for COVID-19 patents with
Severe acute respiratory failure.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Renmin Hospital of Wuhan University Zhongda Hospital Zhongnan Hospital